Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 18;18(1):225.
doi: 10.1186/s12985-021-01699-6.

Predictors of the chest CT score in COVID-19 patients: a cross-sectional study

Niloofar Ayoobi Yazdi #  1 , Abdolkarim Haji Ghadery #  2 , SeyedAhmad SeyedAlinaghi  3 , Fatemeh Jafari  4 , Sirous Jafari  4 , Malihe Hasannezad  4 , Hamid Emadi Koochak  4 , Mohammadreza Salehi  4 , Seyed Ali Dehghan Manshadi  4 , Mohsen Meidani  4 , Mahboubeh Hajiabdolbaghi  4 , Zahra Ahmadinejad  4 , Hossein Khalili  5 , Mohammad-Mehdi Mehrabi Nejad #  6 , Ladan Abbasian #  7
Affiliations
Review

Predictors of the chest CT score in COVID-19 patients: a cross-sectional study

Niloofar Ayoobi Yazdi et al. Virol J. .

Erratum in

Abstract

Background: Since the COVID-19 outbreak, pulmonary involvement was one of the most significant concerns in assessing patients. In the current study, we evaluated patient's signs, symptoms, and laboratory data on the first visit to predict the severity of pulmonary involvement and their outcome regarding their initial findings.

Methods: All referred patients to the COVID-19 clinic of a tertiary referral university hospital were evaluated from April to August 2020. Four hundred seventy-eight COVID-19 patients with positive real-time reverse-transcriptase-polymerase chain reaction (RT-PCR) or highly suggestive symptoms with computed tomography (CT) imaging results with typical findings of COVID-19 were enrolled in the study. The clinical features, initial laboratory, CT findings, and short-term outcomes (ICU admission, mortality, length of hospitalization, and recovery time) were recorded. In addition, the severity of pulmonary involvement was assessed using a semi-quantitative scoring system (0-25).

Results: Among 478 participants in this study, 353 (73.6%) were admitted to the hospital, and 42 (8.7%) patients were admitted to the ICU. Myalgia (60.4%), fever (59.4%), and dyspnea (57.9%) were the most common symptoms of participants at the first visit. A review of chest CT scans showed that Ground Glass Opacity (GGO) (58.5%) and consolidation (20.7%) were the most patterns of lung lesions. Among initial clinical and laboratory findings, anosmia (P = 0.01), respiratory rate (RR) with a cut point of 25 (P = 0.001), C-reactive protein (CRP) with a cut point of 90 (P = 0.002), white Blood Cell (WBC) with a cut point of 10,000 (P = 0.009), and SpO2 with a cut point of 93 (P = 0.04) was associated with higher chest CT score. Lung involvement and consolidation lesions on chest CT scans were also associated with a more extended hospitalization and recovery period.

Conclusions: Initial assessment of COVID-19 patients, including symptoms, vital signs, and routine laboratory tests, can predict the severity of lung involvement and unfavorable outcomes.

Keywords: COVID-19; Chest CT score; Computed tomography; Outcome; Recovery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. WHO Coronavirus (COVID-19) Dashboard [updated 12 July 2021. Available from: https://covid19.who.int/.
    1. Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis. 2020;20(5):e102–e107. - PMC - PubMed
    1. Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005;79(23):14614–14621. - PMC - PubMed
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. - PMC - PubMed
    1. Joshi S, Parkar J, Ansari A, Vora A, Talwar D, Tiwaskar M, et al. Role of favipiravir in the treatment of COVID-19. Int J Infect Dis. 2021;102:501–508. - PMC - PubMed

Publication types

-